You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Colorcon
Harvard Business School
Dow
Mallinckrodt

Last Updated: July 3, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018998


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 018998 describes VASOTEC, which is a drug marketed by Biovail Labs Intl and Bausch and is included in two NDAs. It is available from seven suppliers. Additional details are available on the VASOTEC profile page.

The generic ingredient in VASOTEC is enalapril maleate. There are twenty-seven drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the enalapril maleate profile page.
Summary for 018998
Tradename:VASOTEC
Applicant:Bausch
Ingredient:enalapril maleate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 018998
Medical Subject Heading (MeSH) Categories for 018998
Suppliers and Packaging for NDA: 018998
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VASOTEC enalapril maleate TABLET;ORAL 018998 NDA Valeant Pharmaceuticals North America LLC 0187-0140 0187-0140-30 30 TABLET in 1 BOTTLE (0187-0140-30)
VASOTEC enalapril maleate TABLET;ORAL 018998 NDA Valeant Pharmaceuticals North America LLC 0187-0140 0187-0140-90 90 TABLET in 1 BOTTLE (0187-0140-90)
Paragraph IV (Patent) Challenges for 018998
Tradename Dosage Ingredient NDA Submissiondate
VASOTEC TABLET;ORAL enalapril maleate 018998

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Dec 24, 1985TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Dec 24, 1985TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength20MG
Approval Date:Dec 24, 1985TE:ABRLD:Yes

Expired US Patents for NDA 018998

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bausch VASOTEC enalapril maleate TABLET;ORAL 018998-005 Jul 26, 1988   Start Trial   Start Trial
Bausch VASOTEC enalapril maleate TABLET;ORAL 018998-003 Dec 24, 1985   Start Trial   Start Trial
Bausch VASOTEC enalapril maleate TABLET;ORAL 018998-002 Dec 24, 1985   Start Trial   Start Trial
Bausch VASOTEC enalapril maleate TABLET;ORAL 018998-001 Dec 24, 1985   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Express Scripts
Harvard Business School
Merck
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.